N Alihosseini1, S A Moahboob2, N Farrin2, M Mobasseri3, A Taghizadeh4, A R Ostadrahimi2. 1. Higher Education Institute of Rabe-Rashidi, Tabriz, Islamic Republic of Iran. 2. Nurtition Research Center, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran. 3. Endocrinology Research Center, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran. 4. School of Agriculture, University of Tabriz, Tabriz, Islamic Republic of Iran.
Abstract
BACKGROUND: Probiotic fermented milk is one of the most beneficial foods. The main purpose of this study was to investigate the effect of probiotic fermented milk on the serum level of insulin and homocysteine in the type 2 diabetes patients. METHODS: This study was done in 60 patients with type 2 diabetes. The intervention group received 600 mL of probiotic fermented milk (kefir) daily and control group received 600 mL of conventional fermented milk daily for 8 weeks. Food intake, anthropometric indices, serum parameters were assessed at the beginning and at the end of the study. The statistical analysis was done by the use of SPSS software (Ver.13). RESULTS: The mean of serum insulin level did not reduce significantly after the intervention in probiotic fermented milk group, and there was no significant difference between the two groups. The mean of HOMA-IR decreased significantly in probiotic fermented milk group after intervention and there was a significant difference between the two groups after intervention. The mean of quickie increased in probiotic fermented milk group, but this increase was not significant. Also, there was not significant difference between the two groups after intervention. The mean of homocysteine level decresead significantly in patients with probiotic fermented milk and conventional fermented milk consumption. CONCLUSIONS: By considering the effect of probiotic fermented milk on some risk factors of cardiovascular disease in diabetic patients, probiotic foods may be useful as an adjuvant therapy in diabetic patients.
BACKGROUND: Probiotic fermented milk is one of the most beneficial foods. The main purpose of this study was to investigate the effect of probiotic fermented milk on the serum level of insulin and homocysteine in the type 2 diabetes patients. METHODS: This study was done in 60 patients with type 2 diabetes. The intervention group received 600 mL of probiotic fermented milk (kefir) daily and control group received 600 mL of conventional fermented milk daily for 8 weeks. Food intake, anthropometric indices, serum parameters were assessed at the beginning and at the end of the study. The statistical analysis was done by the use of SPSS software (Ver.13). RESULTS: The mean of serum insulin level did not reduce significantly after the intervention in probiotic fermented milk group, and there was no significant difference between the two groups. The mean of HOMA-IR decreased significantly in probiotic fermented milk group after intervention and there was a significant difference between the two groups after intervention. The mean of quickie increased in probiotic fermented milk group, but this increase was not significant. Also, there was not significant difference between the two groups after intervention. The mean of homocysteine level decresead significantly in patients with probiotic fermented milk and conventional fermented milk consumption. CONCLUSIONS: By considering the effect of probiotic fermented milk on some risk factors of cardiovascular disease in diabetic patients, probiotic foods may be useful as an adjuvant therapy in diabetic patients.
Entities:
Keywords:
Homocysteine; Insulin; Probiotic fermented milk; Type 2 diabetes
Authors: R Aller; D A De Luis; O Izaola; R Conde; M Gonzalez Sagrado; D Primo; B De La Fuente; J Gonzalez Journal: Eur Rev Med Pharmacol Sci Date: 2011-09 Impact factor: 3.507
Authors: N Alexandru; I Jardín; D Popov; M Simionescu; J García-Estañ; G M Salido; J A Rosado Journal: J Cell Mol Med Date: 2008-10 Impact factor: 5.310
Authors: Carla P Vieira; Anisio Iuri L S Rosario; Carini A Lelis; Bruna Samara S Rekowsky; Anna Paula A Carvalho; Denes Kaic A Rosário; Thaísa A Elias; Marion P Costa; Debora Foguel; Carlos A Conte-Junior Journal: Oxid Med Cell Longev Date: 2021-10-27 Impact factor: 6.543